Reappraisal of prognostic factors used in the European Pediatric Soft Tissue Sarcoma Study Group RMS 2005 study for localized rhabdomyosarcoma to optimize risk stratification and generate a prognostic nomogram

Gian Luca De Salvo; Paola Del Bianco; Véronique Minard‐Colin; Julia Chisholm; Meriel Jenney; Gabriela Guillén; Christine Devalck; Rick R. van Rijn; Janet Shipley; Daniel Orbach; Anna Kelsey; Timothy Rogers; Florent Guérin; Giovanni Scarzello; Andrea Ferrari; Maja Česen; Johannes H. M. Merks; Gianni Bisogno

doi:10.1002/cncr.35258

Ask about this paper

Answers are grounded in this paper and cite their sources.

Abstract

The objective of this study was to investigate the role of clinical factors together with FOXO1 fusion status in patients with nonmetastatic rhabdomyosarcoma (RMS) to develop a predictive model for event-free survival and provide a rationale for risk stratification in future trials.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Salvo et al. (2024) studied this question.

synapsesocial.com/papers/68e77b43b6db6435876efea5 https://doi.org/10.1002/cncr.35258

View Full Paper

Ask AI

Bookmark

Share

Reappraisal of prognostic factors used in the European Pediatric Soft Tissue Sarcoma Study Group RMS 2005 study for localized rhabdomyosarcoma to optimize risk stratification and generate a prognostic nomogram

Ask about this paper

Abstract

Discussion

Cite This Study

Reappraisal of prognostic factors used in the European Pediatric Soft Tissue Sarcoma Study Group RMS 2005 study for localized rhabdomyosarcoma to optimize risk stratification and generate a prognostic nomogram

Ask about this paper

Abstract

Discussion

Cite This Study

Keep reading

Keep reading